Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing.
Takeshita T, Iwamoto T, Niikura N, Watanabe K, Kikawa Y, Kobayashi K, Iwakuma N, Okamura T, Tada H, Ozaki S, Okuno T, Toh U, Yamamoto Y, Tsuneizumi M, Ishiguro H, Masuda N, Saji S.
Takeshita T, et al. Among authors: saji s.
ESMO Open. 2024 Feb 21;9(4):102385. doi: 10.1016/j.esmoop.2024.102385. Online ahead of print.
ESMO Open. 2024.
PMID: 38387111
Free article.